Carregant...
Chloroquine and nanoparticle drug delivery: A promising combination
Clinically approved cancer therapies include small molecules, antibodies, and nanoparticles. There has been major progress in the treatment of several cancer types over recent decades. However, many challenges remain for optimal use of conventional and nanoparticle-based therapies in oncology includ...
Guardat en:
| Publicat a: | Pharmacol Ther |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6677248/ https://ncbi.nlm.nih.gov/pubmed/29932886 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2018.06.007 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|